Akari Therapeutics, Plc (AKTX) Operating cash flow 2016–2025
Akari Therapeutics, Plc (AKTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.6MFY2025 · since FY2016: -$24.6M → -$10.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.6M | +15.8% |
| FY2024 | -$12.6M | +23.6% |
| FY2023 | -$16.4M | +23.6% |
| FY2022 | -$21.5M | -14.1% |
| FY2021 | -$18.8M | -11.2% |
| FY2020 | -$17.0M | -31.2% |
| FY2019 | -$12.9M | +43.3% |
| FY2018 | -$22.8M | +27.9% |
| FY2017 | -$31.6M | -28.3% |
| FY2016 | -$24.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice